BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 6944154)

  • 1. Chromosomal anomaly of 6q in chronic myelogenous leukemia (CML).
    Srivastava AK; Gruppo RA; Siegrist CW
    Cancer Genet Cytogenet; 1981 Mar; 3(2):131-6. PubMed ID: 6944154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17p+ in a patient with chronic myelogenous leukemia (CML): its differentiation from an isochromosome 17,[i(17q)].
    Verma RS; Dosik H
    Cancer Genet Cytogenet; 1981 Jan; 3(1):55-60. PubMed ID: 6944152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two apparent Philadelphia chromosomes arising from translocations with different chromosomes in a patient with CML: 46,XY,t(7;22)(p22;q11),t(9;22)(q34;q11).
    Holden JJ; Simpson J; Ginsburg A; Smith A; Hughes P
    Cancer Genet Cytogenet; 1986 Apr; 21(4):297-302. PubMed ID: 3456823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant Ph1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises.
    Oshimura M; Ohyashiki K; Terada H; Takaku F; Tonomura A
    Cancer Genet Cytogenet; 1982 Mar; 5(3):187-201. PubMed ID: 6950809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex chromosomal abnormalities in a patient with lymphoid blast crisis of chronic myelogenous leukemia.
    Haubenstock A; Kim HJ; Zalusky R; Malamud SC; Mernick MH
    Am J Hematol; 1986 Aug; 22(4):435-7. PubMed ID: 3460329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelogenous leukemia with translocations (3q-;9q+) and (17q-;22q+). Possible crucial cytogenetic events in the genesis of CML.
    Oshimura M; Ohyashiki K; Vehara M; Miyasaka Y; Osamura S; Tonomura A
    Hum Genet; 1981; 57(1):48-51. PubMed ID: 6943121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of reverse banding in detecting bone marrow chromosomal abnormalities: translocation between chromosomes 1, 9, and 22 in a case of chronic myelogenous leukemia (CML).
    Verma RS; Dosik H
    Am J Hematol; 1977; 3():171-5. PubMed ID: 272121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic heterogeneity in blast crisis (BC) of chronic myelogenous leukemia (CML).
    Abramson J; Verma RS; Schwartz J
    Blut; 1985 Nov; 51(5):361-3. PubMed ID: 3864501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isochromosome (17q) in Philadelphia chromosome (Ph1)-negative juvenile chronic myelocytic leukemia.
    Casalone R; Francesconi D; Pasquali F; Comotti B; Vaccari F
    Cancer Genet Cytogenet; 1981 Mar; 3(2):145-8. PubMed ID: 6944155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome abnormalities involving heterochromatic regions in monocytic leukemia.
    Rege-Cambrin G; Kerim S; Scaravaglio P; Michaux JL; Van den Berghe H; Saglio G
    Cancer Genet Cytogenet; 1990 May; 46(1):99-106. PubMed ID: 2331689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long arm deletion of chromosome 5 in a case of chronic myelomonocytic leukemia.
    Sato Y; Kubota K; Suda K; Tsuboyama A; Sakamoto S; Miura Y
    Cancer Genet Cytogenet; 1985 Feb; 15(3-4):269-75. PubMed ID: 3855687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome abnormalities in chronic myeloid leukemia in children.
    Puchkova GP; Prigogina EL; Fleischmann EW; Drosdova TS; Mayakova SA; Peterson IS
    Hum Genet; 1983; 64(3):257-62. PubMed ID: 6576982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia (CML) with translocation (8;22): a new variant.
    Turchini MF; Geneix A; Delaroque A; Marques-Verdier A; Travade P; Malet P
    Cancer Genet Cytogenet; 1983 Oct; 10(2):187-90. PubMed ID: 6577940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four cases with complex Philadelphia translocations, including one with appearance de novo of a "masked" Ph.
    Ohyashiki K; Ohyashiki JH; Otaki K; Yoshida MA; Raza A; Preisler HD; Sandberg AA
    Cancer Genet Cytogenet; 1987 Feb; 24(2):281-94. PubMed ID: 3466678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocations (4p+; 6q-) and (12q-; Xp+) in blastic phase of a Ph1-positive chronic myeloid leukemia.
    Suciu S; Marinca E; Bornuz F; Crisan M; Petrov L; Rădulescu E
    Blut; 1984 Oct; 49(4):325-30. PubMed ID: 6593103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different cell clones in bone marrow and spleen of a patient with chronic myelocytic leukemia (CML) in blastic phase.
    Olinici CD; Petrov L; Macavei I; Dobay O
    Cancer; 1978 Dec; 42(6):2707-9. PubMed ID: 282004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-random karyotypic evolution in chronic myeloid leukemia.
    Mitelman F; Levan G; Nilsson PG; Brandt L
    Int J Cancer; 1976 Jul; 18(1):24-30. PubMed ID: 1065618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Y chromosome duplication in chronic myeloid leukemia.
    Stoll C; Oberling F
    Nouv Rev Fr Hematol (1978); 1982; 24(1):9-12. PubMed ID: 6951142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-analysis of the cell line NALM-1 karyotype by GTG-banding, spectral karyotyping, and whole chromosome painting.
    Pelz AF; Weilepp G; Wieacker PF
    Cancer Genet Cytogenet; 2005 Jan; 156(1):59-61. PubMed ID: 15588857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masked Ph chromosome due to a new type of translocation in a patient with chronic myelogenous leukemia.
    Miura I; Hashimoto K; Nishinari T; Miura AB; Komatsu K; Tsuji E; Yatabe M; Higashi O
    Cancer Genet Cytogenet; 1988 Aug; 34(1):53-5. PubMed ID: 3165049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.